Mitsubishi UFJ Asset Management
TEVA icon

Mitsubishi UFJ Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5M Buy
1,372,243
+143,068
+12% +$4.77M 0.03% 421
2026
Q1 		$37M Buy
1,229,175
+146,597
+14% +$4.72M 0.02% 433
2025
Q4 		$33.5M Buy
1,082,578
+80,106
+8% +$1.97M 0.02% 451
2025
Q3 		$20.2M Hold
1,002,472
– – 0.01% 502
2025
Q2 		$16.8M Buy
1,002,472
+141,143
+16% +$2.28M 0.01% 516
2025
Q1 		$13.2M Buy
861,329
+53,443
+7% +$955K 0.01% 544
2024
Q4 		$17.2M Buy
807,886
+70,978
+10% +$1.29M 0.02% 508
2024
Q3 		$13.3M Buy
736,908
+43,228
+6% +$757K 0.01% 533
2024
Q2 		$11.3M Buy
693,680
+65,989
+11% +$1.02M 0.01% 533
2024
Q1 		$8.86M Buy
627,691
+167,097
+36% +$2.11M 0.01% 550
2023
Q4 		$5.04M Hold
460,594
– – 0.01% 602
2023
Q3 		$4.7M Hold
460,594
– – 0.01% 608
2023
Q2 		$3.47M Buy
460,594
+76,684
+20% +$622K 0.01% 660
2023
Q1 		$3.4M Buy
383,910
+43,245
+13% +$428K 0.01% 644
2022
Q4 		$3.25M Hold
340,665
– – 0.01% 633
2022
Q3 		$2.75M Buy
340,665
+45,149
+15% +$399K 0.01% 651
2022
Q2 		$2.22M Buy
295,516
+43,987
+17% +$383K 0.01% 686
2022
Q1 		$2.36M Sell
251,529
-6,866
-3% -$57.3K 0.01% 702
2021
Q4 		$2.15M Buy
258,395
+9,759
+4% +$88.1K 0.01% 740
2021
Q3 		$2.42M Hold
248,636
– – 0.01% 708
2021
Q2 		$2.46M Buy
248,636
+24,844
+11% +$263K 0.01% 707
2021
Q1 		$2.58M Buy
223,792
+12,004
+6% +$138K 0.02% 649
2020
Q4 		$2.04M Buy
211,788
+10,330
+5% +$99K 0.02% 652
2020
Q3 		$1.81M Buy
201,458
+26,083
+15% +$276K 0.02% 604
2020
Q2 		$2.16M Buy
175,375
+12,586
+8% +$142K 0.02% 522
2020
Q1 		$1.46M Sell
162,789
-4,541
-3% -$46.5K 0.02% 539
2019
Q4 		$1.52M Buy
167,330
+18,793
+13% +$168K 0.02% 607
2019
Q3 		$1.02M Sell
148,537
-1,796
-1% -$13.8K 0.02% 617
2019
Q2 		$1.39M Buy
150,333
+31,894
+27% +$385K 0.02% 551
2019
Q1 		$1.86M Buy
118,439
+9,876
+9% +$174K 0.04% 423
2018
Q4 		$1.79M Sell
108,563
-13,732
-11% -$282K 0.05% 368
2018
Q3 		$2.63M Buy
122,295
+9,490
+8% +$220K 0.05% 336
2018
Q2 		$2.74M Buy
112,805
+3,331
+3% +$67.9K 0.06% 314
2018
Q1 		$1.87M Sell
109,474
-11,864
-10% -$232K 0.04% 410
2017
Q4 		$2.32M Sell
121,338
-6,162
-5% -$92.7K 0.05% 371
2017
Q3 		$2.24M Buy
127,500
+7,800
+7% +$176K 0.05% 355
2017
Q2 		$3.98M Sell
119,700
-16,816
-12% -$521K 0.1% 213
2017
Q1 		$4.38M Buy
136,516
+1,562
+1% +$53.3K 0.1% 212
2016
Q4 		$5.06M Buy
+134,954
New +$5.39M 0.12% 172

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mitsubishi UFJ Asset Management's TEVA Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $4.77M and bringing the position to 1,372,243 shares worth $46.5M. The position accounts for 0.03% of the portfolio, ranked #421.

Mitsubishi UFJ Asset Management first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 1,372,243 shares of Teva Pharmaceuticals worth $46.5M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 143,068 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.77M.
  • Teva Pharmaceuticals made up 0.03% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #421 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.